Dr. Spinler is Professor of Clinical Pharmacy in the Department of Pharmacy Practice and Pharmacy Administration at the Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. She is also an adjunct faculty member in the Cardiovascular Division in the Department of Medicine at the University of Pennsylvania. Dr. Spinler received her Bachelor of Science and Doctor of Pharmacy degrees from the University of Minnesota in Minneapolis. She completed a pharmacy residency and fellowship in cardiovascular critical care pharmacy at the University of Illinois at Chicago. She became a Board Certified Pharmacotherapy Specialist in 2006. She serves as a preceptor to pharmacy students and performs clinical research at the Hospital of the University of Pennsylvania, coronary intensive care unit. Dr. Spinler has authored more than 100 research articles, reviews, and books chapters in the area of antithrombotic therapy. She is a Fellow of the American College of Clinical Pharmacy (ACCP) and a member of the American Society of Health-System Pharmacists. She was awarded the 2004 American Society of Health-System Pharmacists Award for Sustained Contributions to the Literature of Pharmacy Practice and served served as a Regent of ACCP from 2004 to 2007. She is Chair, 2005-2010 Council of Experts, United States Pharmacopeia, Cardiovascular Expert Committee. As
Toby Trujillo
PROGRAM CHAIR:
Michael Crouch
LEARNER OUTCOMES:
Describe the current state of antiplatelet therapy for the maintenance of stent patency.
Describe the future direction of antiplatelet therapy with two new medications on the immediate horizon.
Explain the predominant mechanisms of antiplatelet nonresponsiveness.
Identify the clinical consequences of antiplatelet nonresponsiveness.
Summarize the current trends and guideline statements related to antiplatelet therapy.